共 148 条
[1]
Wild SH(2004)Global prevalence of diabetes: estimates for the year 2000 and projections for 2030: response to Rathman and Giani Diabetes Care 27 2569-293
[2]
Roglic G(2019)Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas Diabetes Res Clin Pract 157 107843-2833
[3]
Green A(2019)Burden of diabetes, hyperglycaemia in China from to 2016: findings from the 1990 to 2016, global burden of disease study Diabetes Metab 45 286-806
[4]
Sicree R(2015)Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus Expert Opin Pharmacother 16 2819-684
[5]
King H(2001)Insulin signalling and the regulation of glucose and lipid metabolism Nature. 414 799-2581
[6]
Saeedi P(1986)Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus Arteriosclerosis 6 679-3986
[7]
Petersohn I(2002)Diabetes and atherosclerosis: epidemiology, pathophysiology, and management Jama. 287 2570-331
[8]
Salpea P(2015)Insulin, aging, and the brain: mechanisms and implications Front Endocrinol 6 13-233
[9]
Malanda B(2013)Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions Diabetes. 62 3976-598
[10]
Karuranga S(2010)Natural products as α-amylase and α-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update Mini Rev Med Chem 10 315-234